StockNews.AI

CORRECTION – Visionary Holdings Inc.

StockNews.AI • 3 hours

AMGNABBVNVS
High Materiality7/10

Information

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holding...

Original source

AI Summary

GV reports a strategic transformation towards health management and medical aesthetics. Fiscal year 2025 revenue decreased by 46.2%, totaling USD 5.04 million. Emerging health businesses contributed 21.1% to total revenue, indicating growth potential. The company faces liquidity pressures with a net loss of USD 15.75 million. CEO highlights commercialization efforts in premium aesthetics and health management.

Sentiment Rationale

The significant revenue decrease and net loss overshadow emerging business growth. Historically, transitions take time to reflect in stock prices.

Trading Thesis

The transformation into health sectors may yield benefits over several years, similar to other companies in this domain.

Market-Moving

  • GV reports a strategic transformation towards health management and medical aesthetics.
  • Fiscal year 2025 revenue decreased by 46.2%, totaling USD 5.04 million.
  • Emerging health businesses contributed 21.1% to total revenue, indicating growth potential.

Key Facts

  • GV reports a strategic transformation towards health management and medical aesthetics.
  • Fiscal year 2025 revenue decreased by 46.2%, totaling USD 5.04 million.
  • Emerging health businesses contributed 21.1% to total revenue, indicating growth potential.
  • The company faces liquidity pressures with a net loss of USD 15.75 million.
  • CEO highlights commercialization efforts in premium aesthetics and health management.

Companies Mentioned

  • AMGN (AMGN)
  • ABBV (ABBV)
  • NVS (NVS)

Corporate Developments

The ongoing changes and financial performance are crucial indicators for investors assessing GV’s future.

Visionary Holdings Inc. (Nasdaq: GV) Releases Annual Report for Fiscal Year 2025

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) – Visionary Holdings Inc. (Nasdaq: GV) has announced the public release of its final annual report and audited financial statements for the fiscal year ended March 31, 2025. This update comes as part of a correction to earlier reports that did not adequately reflect comments from the U.S. Securities and Exchange Commission (SEC).

Overview of Financial Performance

During the fiscal year, Visionary Holdings Inc. made significant strides in shifting its business model from traditional education and real estate towards a diversified platform focusing on health management and anti-aging, alongside premium medical aesthetics. Notably, the company's emerging health-related businesses generated initial revenue contributions, marking early progress in its strategic repositioning.

A summary of financial highlights for fiscal year 2025 includes:

  • Total revenue: USD 5.04 million, a decline of 46.2% year-over-year.
  • Net loss: USD 15.75 million due to transformation-related investments and asset impairment charges.
  • Gross margin: Improved to 28.0%, with education services achieving a gross margin of 64.4%.
  • Cash flow from investing activities: USD 14.51 million, supporting liquidity during the transitional period.

Despite a challenging fiscal environment, management noted that revenue from emerging businesses accounted for approximately 21.1% of total revenue, indicating an early stage of successful business restructuring.

Strategic Transformation and Business Developments

Visionary Holdings Inc. is undergoing a strategic transformation focused on several key areas:

Health Management Sector

The company is exploring health management initiatives, including gastrointestinal health solutions. Progress in this sector has involved market testing and early-stage commercialization efforts in Asia, supported by partnerships aimed at service delivery.

Anti-Aging and Medical Aesthetics

In the realm of anti-aging and premium medical aesthetics, Visionary Holdings has begun establishing strategic collaborations. Partnerships with Jiangsu Yike Regenerative Medicine Technology Co., Ltd. and Anhui Weikang Kangling Medical Technology Co., Ltd. aim to enhance the company's service offerings and competitive positioning.

AI-Enabled Education Business

The AI education segment remains stable, providing various educational programs while collaborating with Canadian institutions to support international students.

CEO Commentary on Fiscal Transformation

Mr. Xiyong Hou, CEO of Visionary Holdings, emphasized the importance of the fiscal year 2025 in solidifying the company's transformation strategy. He noted, “The initial revenue contributions from emerging businesses during the reporting period validated our transition towards health management, anti-aging, and premium medical aesthetics.”

He further highlighted the focus on high-potential segments and the company's commitment to enhancing corporate governance and internal controls, aiming for sustainable growth and long-term value creation for shareholders.

Outlook for Future Growth

Looking ahead, Visionary Holdings Inc. plans to:

  • Explore further commercialization opportunities in health management and premium medical aesthetics.
  • Advance its business model towards service-driven offerings aligned with market demands.

As Visionary Holdings Inc. moves forward, the management will continue to implement prudent measures to address liquidity challenges and pursue strategic growth prospects within the evolving healthcare landscape.

For more information, be sure to stay tuned for the Company's future announcements regarding the filing of its Annual Report on Form 20-F with the SEC.

Related News